Genomics

Dataset Information

0

FH enhances the therapeutic effect of PD-1 inhibitors on colorectal cancer by inhibiting the expression of PCSK9.

ABSTRACT: FH enhances the therapeutic effect of PD-1 inhibitors on colorectal cancer by inhibiting the expression of PCSK9.

PROVIDER: PRJNA1028564 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR26397800_1.fastq.gz Fastqsanger.gz
SRR26397800_2.fastq.gz Fastqsanger.gz
SRR26397795_1.fastq.gz Fastqsanger.gz
SRR26397795_2.fastq.gz Fastqsanger.gz
SRR26397796_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 12

Similar Datasets

Transcriptomics FH enhances the therapeutic effect of PD-1 inhibitors on colorectal cancer by inhibiting the expression of PCSK9.
2024-12-31 | GSE245475 | GEO
Other Small Molecule PCSK9 Inhibitors: Hit to lead optimization
2018-06-20 | GSE110426 | GEO
Genomics Mycoplasmoides pneumoniae FH strain:FH
| PRJNA182276 | ENA
Genomics Mycoplasmoides pneumoniae FH strain:FH
| PRJNA46155 | ENA
Genomics Mycoplasmoides pneumoniae FH strain:FH
| PRJNA73095 | ENA
Transcriptomics Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9
2008-01-30 | E-MEXP-1235 | biostudies-arrayexpress
Genomics Mycoplasmoides pneumoniae FH strain:FH
| PRJNA49525 | ENA
Transcriptomics Genome-wide expression profile in FH-deficient (UOK262) vs FH-competent (UOK262pFH) human cells derived from metastatsis to the mediastinum of a HLRCC patient
2016-09-22 | GSE77538 | GEO
Genomics Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
| PRJNA1117900 | ENA
Genomics Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
| PRJNA972474 | ENA